https://www.selleckchem.com/products/sb297006.html
7% at 1 year to 2.7% at 5 years. Total vaginal length 7.5 cm (TVL, OR = 2.7, 95% CI 1.3-5.7, P = 0.007), improvement in Urinary Impact Questionnaire-7 scores 50% at 3 months (OR = 2.1, 95% CI 1.1-4.2, P = 0.025), and incapability of self-care (OR = 2.6, 95% CI 1.3-5.1, P = 0.008) were potential discontinuation risk factors. Three-quarters of patients with symptomatic POP had successful pessary treatment at 5-year follow-up. TVL 7.5 cm, poor urinary symptom relief at 3 months, and incapability of self-care were potential